EUVIMEDEUVIMED entdecken
Crossref

Pharmacokinetic interactions of clozapine and olanzapine: case studies of drug modifications due to CYP1A2 inhibition

Kateřina Skopalová

Klinická farmakologie a farmacie · 30.10.2025 · 39 (3) · 181-184

DOI: 10.36290/far.2025.063 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Klinická farmakologie a farmacie, erschienen am 30.10.2025. Verfasst von Kateřina Skopalová. Die Arbeit nennt 18 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Skopalová, K. (2025). Pharmacokinetic interactions of clozapine and olanzapine: case studies of drug modifications due to CYP1A2 inhibition. Klinická farmakologie a farmacie, 39(3), 181-184. https://doi.org/10.36290/far.2025.063

Vancouver

Skopalová K. Pharmacokinetic interactions of clozapine and olanzapine: case studies of drug modifications due to CYP1A2 inhibition. Klinická farmakologie a farmacie. 2025;39(3):181-184. doi:10.36290/far.2025.063

BibTeX
@article{Skopalov2025,
  author = {Skopalová, Kateřina},
  title = {Pharmacokinetic interactions of clozapine and olanzapine: case studies of drug modifications due to CYP1A2 inhibition},
  journal = {Klinická farmakologie a farmacie},
  year = {2025},
  volume = {39},
  number = {3},
  pages = {181--184},
  doi = {10.36290/far.2025.063}
}
Kostenlos starten →